E-cigarette rules go into effect

New rules about e-cigarettes went into effect Feb. 6, with a partial ban on some flavored products in the U.S. market.

The Trump administration announced it would ban flavored vaping products in September 2019, after thousands of lung diseases associated with e-cigarette use were reported across the country, as well as dozens of deaths. While President Trump backed off the original hard line ban, the administration moved forward with a plan to prohibit the sale of some products as they undergo review from the FDA.

The lung illness linked to vaping was named e-cigarette, or vaping, product use-associated lung injury (EVALI) by the CDC, which also narrowed down vitamin E acetate as the potential chemical causing health harm and death. Patients with EVALI were reported to present with shortness of breath, fever, chills, cough, chest tightness, belly pain and more.

As of Jan. 28, 2020, 2,711 hospitalized EVALI cases were reported in the U.S., according to the CDC. Sixty deaths have occurred. The spread of the illness prompted CMS to create a new ICD-10 code for healthcare providers, starting April 1.

The new e-cigarette sale rules do not apply to menthol or tobacco flavors of vaping products, and the rule only affect cartridge-based e-cigarettes. Companies are required to stop manufacturing, distributing and selling fruit and mint flavored vaping products.

Critics of the rule say it doesn’t go far enough, with menthol being one of the most popular flavors on the market. E-cigarettes have sparked major concern over the last few years, as huge numbers of young people use them and their long-term health impacts are unknown.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”